肠道甲状腺激素代谢及其临床意义综合综述
本文综述肠道甲状腺激素代谢及其临床意义。肠道是甲状腺激素靶器官,微生物通过解结合酶参与外周甲状腺激素代谢;肠道菌群失调与自身免疫性甲状腺疾病相关,但因果关系尚待前瞻性队列研究、随机临床试验和实验研究证实。
要点
- 肠道上皮细胞表达甲状腺激素受体α1,甲状腺激素经肝硫酸化和葡萄糖醛酸化部分代谢。
- 肠道微生物产生β-葡萄糖醛酸酶和硫酸酯酶,使甲状腺激素重新进入肠肝循环。
- 肠道菌群失调与桥本甲状腺炎、Graves病和Graves眼病相关,但因果关系尚待证实。
核心结论
- 本综述旨在全面阐述甲状腺激素代谢与肠道稳态之间的相互作用。
- 肠道菌群在甲状腺疾病发病机制中的作用提供了新见解,可能成为自身免疫性甲状腺疾病微生物组疗法的初步步骤,但因果关系机制尚待证实。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- 肠道是甲状腺激素靶器官,其作用通过肠上皮细胞表达的核甲状腺激素受体α1介导。
- 甲状腺激素部分经肝硫酸化和葡萄糖醛酸化代谢,生成结合型碘甲状腺原氨酸。
- 肠道微生物产生并分泌具有解结合活性的酶(β-葡萄糖醛酸酶和硫酸酯酶),使甲状腺激素重新进入肠肝循环。
- 肠道上皮稳态由三碘甲状腺原氨酸与甲状腺激素受体α1的交互作用、特定甲状腺激素转运体及甲状腺激素激活和失活酶的存在共同调控。
- 携带甲状腺激素受体α显性负突变的患者和小鼠模型肠道上皮形态严重异常,并出现严重的胃肠道功能障碍症状。
关键数值与推荐
- 肠道菌群失调与自身免疫性甲状腺疾病相关,包括桥本甲状腺炎、Graves病和Graves眼病。
- 因果关系机制尚待证实,需要前瞻性队列研究、随机临床试验和实验研究。
临床怎么用
- 原文未据此给出推荐。
局限性
- 因果关系机制尚待证实,需要前瞻性队列研究、随机临床试验和实验研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The gut is a target organ of thyroid hormone (TH) that exerts its action via the nuclear thyroid hormone receptor α1 (TRα1) expressed in intestinal epithelial cells. THs are partially metabolized via hepatic sulfation and glucuronidation, resulting in the production of conjugated iodothyronines. Gut microbiota play an important role in peripheral TH metabolism as they produce and secrete enzymes with deconjugation activity (β-glucuronidase and sulfatase), via which TH can re-enter the enterohepatic circulation. Summary: Intestinal epithelium homeostasis (the finely tuned balance between cell proliferation and differentiation) is controlled by the crosstalk between triiodothyronine and TRα1 and the presence of specific TH transporters and TH-activating and -inactivating enzymes. Patients and experimental murine models with a dominant-negative mutation in the TRα exhibit gross abnormalities in the morphology of the intestinal epithelium and suffer from severe symptoms of a dysfunctional gastrointestinal tract. Over the past decade, gut microbiota has been identified as an essential factor in health and disease, depending on its compositional and functional profile. This has led to a renewed interest in the so-called gut-thyroid axis. Disruption of gut microbial homeostasis (dysbiosis) is associated with autoimmune thyroid disease (AITD), including Hashimoto's thyroiditis, Graves' disease, and Graves' orbitopathy. These studies reviewed here provide new insights into the gut microbiota roles in thyroid disease pathogenesis and may be an initial step toward microbiota-based therapies in AITD. However, it should be noted that cause-effect mechanisms remain to be proven, for which prospective cohort studies, randomized clinical trials, and experimental studies are needed. Conclusion: This review aims at providing a comprehensive insight into the interplay between TH metabolism and gut homeostasis.
引用
- Fenneman AC, Bruinstroop E, Nieuwdorp M, et al. A Comprehensive Review of Thyroid Hormone Metabolism in the Gut and Its Clinical Implications. Thyroid. 2023. PMID: 36322786. doi:10.1089/thy.2022.0491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。